Insight Into Market Ahead - Equity Research on Gilead Sciences, Inc. and Bristol Myers Squibb Co.

Date:2011-08-19xujintao  Text Size:

HONG KONG, Aug 18, 2011 (MARKETWIRE via COMTEX) -- Today, released its industry report highlighting Gilead Sciences, Inc. /quotes/zigman/72849/quotes/nls/gild GILD -0.07% and Bristol Myers Squibb Co. /quotes/zigman/220498/quotes/nls/bmy BMY +0.54% . Full fundamental and technical analysis is available at .

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

World Street Fundamentals has highlighted Gilead Sciences, Inc. as a biopharmaceutical company. The Company focuses on the development and commercialization of human therapeutics for life threatening diseases. The Company has operations in North America, Europe and Asia Pacific. The entire report on Gilead Sciences, Inc. /quotes/zigman/72849/quotes/nls/gild GILD -0.07% is available.

World Street has featured Bristol Myers Squibb Co. as a company which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The entire report on Bristol Myers Squibb Co. /quotes/zigman/220498/quotes/nls/bmy BMY +0.54% is available .

About World Street World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.

2005-2011 All Rights Reserved 京ICP备05069564号-1